Authors: Marmont, F Allione, B Audisio, E Boccomini, C Ciocca, V D'Ardia, S Falda, M Locatelli, F Gallo, E

Citation: F. Marmont et al., A landmark analysis of survival by response category in elderly patients with acute myeloblastic leukemia, HEMAT BLOOD, 40, 2001, pp. 644-646

Authors: Palumbo, A Triolo, S Baldini, L Callea, V Capaldi, A De Stefano, V Grasso, M Liberati, M Lotesoriere, C Marceno, R Marmont, F Musto, P Petrucci, MT Spriano, M Pileri, A Boccadoro, M

Citation: A. Palumbo et al., Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients, HAEMATOLOG, 85(5), 2000, pp. 508-513

Authors: Affaticati, P Locatelli, F Roggero, S Marmont, F Falda, M Dall'Omo, AM Busca, A Ceretto, C Pratico, L Berrino, M Curtoni, ES

Citation: P. Affaticati et al., Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings, BONE MAR TR, 26(5), 2000, pp. 517-523

Authors: Boccadoro, M Tarella, C Palumbo, A Argentino, C Triolo, S Dominietto, A Callea, V Lauta, VM Molica, S Musto, P Marmont, F Gianni, AM Pileri, A

Citation: M. Boccadoro et al., An analysis of which subgroups of multiple myeloma patients, divided according to beta(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy, HAEMATOLOG, 84(10), 1999, pp. 905-910